5 Indian pharma firms await regulator’s nod to make Remdesivir

| Jun 08, 2020, 11:10:19 AM | TOI.in
  • Share
Five Indian pharma companies have applied to the DCGI seeking permission to manufacture and sell Remdesivir in India. These companies have signed a licensing agreement with US drugmaker Gilead Sciences which is the original developer. Despite rapidly rising Covid-19 deaths and an approval to use the drug, Indian patients are still waiting for it to be available. The regulator has asked companies to submit various sets of data, including stability study, animal toxicity. Local manufacturers said they had everything in place, starting from raw material to capacity, and were only waiting for regulatory approval to start manufacturing the drug.

Top Viral Videos

Short Videos